GRFS · NASDAQ · Drug Manufacturers - General

Grifols (ADR)

Builds plasma-derived therapies, diagnostics, and biologic supplies around an integrated plasma network.

$7.69
After-hours close0.00 (0.00%)
At close$7.69(−1.66%)
DateEstimateReportedSurprise
Nov 2026$0.29
Jul 2026$0.27$0.25−7.0%
May 2026$0.16$0.17+7.3%
Feb 2026$0.29$0.29−0.3%
Nov 2025$0.24$0.22−9.6%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 2025
May 2025
Mar 2025
Nov 2024
Jul 2024
May 2024
Mar 2024
Nov 2023
Jul 2023
May 2023
Mar 2023
Feb 2023
Jul 2022
May 2022
Feb 2022
Dec 2021
Jul 2021
May 2021
Feb 2021
Nov 2020
Jul 2020
Apr 2020
Feb 2020
Oct 2019
Jul 2019
May 2019
Feb 2019
Nov 2018
Jul 2018
May 2018
Feb 2018
Nov 2017
Jul 2017
May 2017
Feb 2017
Nov 2016
Jul 2016
May 2016
Feb 2016
Nov 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 10, 2026$0.29$2.25B
Jul 28, 2026$0.27$0.25−7.0%$2.17B$2.13B−1.5%
May 7, 2026$0.16$0.17+7.3%$2.03B$2.00B−1.4%
Feb 26, 2026$0.29$0.29−0.3%$2.34B$2.34B−0.2%
Nov 4, 2025$0.24$0.22−9.6%$2.15B$2.18B+1.5%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 28, 2025
May 12, 2025
Mar 6, 2025
Nov 7, 2024
Jul 30, 2024
May 14, 2024
Mar 5, 2024
Nov 2, 2023
Jul 27, 2023
May 16, 2023
Mar 13, 2023
Feb 27, 2023
Jul 28, 2022
May 5, 2022
Feb 28, 2022
Dec 30, 2021
Jul 29, 2021
May 4, 2021
Feb 26, 2021
Nov 5, 2020
Jul 30, 2020
Apr 21, 2020
Feb 27, 2020
Oct 29, 2019
Jul 31, 2019
May 7, 2019
Feb 28, 2019
Nov 5, 2018
Jul 27, 2018
May 3, 2018
Feb 28, 2018
Nov 2, 2017
Jul 28, 2017
May 3, 2017
Feb 28, 2017
Nov 8, 2016
Jul 28, 2016
May 5, 2016
Feb 29, 2016
Nov 4, 2015
Jul 30, 2015